Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Chubb
Healthtrust
Colorcon
McKinsey
Novartis
US Army
Accenture
Medtronic
Julphar

Generated: August 21, 2017

DrugPatentWatch Database Preview

Claims for Patent: ► Subscribe

« Back to Dashboard

Claims for Patent: ► Subscribe

Title:Diamine derivatives
Abstract: A compound represented by the general formula (1): Q.sup.1-Q.sup.2-T.sup.0-N(R.sup.1)-Q.sup.3-N(R.sup.2)-T.sup.1-Q.sup.4 (1) wherein R.sup.1 and R.sup.2 are hydrogen atoms or the like; Q.sup.1 is a saturated or unsaturated, 5- or 6-membered cyclic hydrocarbon group which may be substituted, or the like; Q.sup.2 is a single bond or the like; Q.sup.3 is a group ##STR00001## in which Q.sup.5 is an alkylene group having 1 to 8 carbon atoms, or the like; and T.sup.0 and T.sup.1 are carbonyl groups or the like; a salt thereof, a solvate thereof, or an N-oxide thereof. The compound is useful as an agent for preventing and/or treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism, Buerger's disease, deep venous thrombosis, disseminated intravascular coagulation syndrome, thrombus formation after valve or joint replacement, thrombus formation and reocclusion after angioplasty, systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), thrombus formation during extracorporeal circulation, or blood clotting upon blood drawing.
Inventor(s): Ohta; Toshiharu (Tokyo, JP), Komoriya; Satoshi (Tokyo, JP), Yoshino; Toshiharu (Tokyo, JP), Nagamochi; Masatoshi (Tokyo, JP), Ono; Makoto (Tokyo, JP)
Assignee: Daiichi Sankyo Company, Limited (Tokyo, JP)
Application Number:10/481,262
Patent Claims: 1. N.sup.1-(5-chloropyridin-2-yl)-N.sup.2-(4-[(dimethylamino)carbonyl]-2-- {[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino}c- yclohexyl)ethanediamide, a salt thereof, ##STR00801##

2. N.sup.1-(5-chloropyridin-2-yl)-N.sup.2-(4-[(dimethylamino)carbonyl]-2-- {[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino}c- yclohexyl)ethanediamide p-toluenesulfonate ##STR00802##

3. N.sup.1-(5-chloropyridin-2-yl)-N.sup.2-(4-[(dimethylamino)carbonyl]-2-- {[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino}c- yclohexyl)ethanediamide p-toluenesulfonate monohydrate ##STR00803##

4. N.sup.1-(5-chloropyridin-2-yl)-N.sup.2-((1S,2R,4S)-4-[(dimethylamino)c- arbonyl]-2-{[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbo- nyl]amino}cyclohexyl)ethanediamide, a salt thereof, ##STR00804##

5. N.sup.1-(5-chloropyridin-2-yl)-N.sup.2-((1S,2R,4S)-4-[(dimethylamino)c- arbonyl]-2-{[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbo- nyl]amino}cyclohexyl)ethanediamide p-toluenesulfonate. ##STR00805##

6. N.sup.1-(5-chloropyridin-2-yl)-N.sup.2-((1S,2R,4S)-4-[(dimethylamino)c- arbonyl]-2-{[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbo- nyl]amino}cyclohexyl)ethanediamide p-toluenesulfonate monohydrate ##STR00806##
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Farmers Insurance
Baxter
Teva
Covington
Cipla
Johnson and Johnson
Fish and Richardson
Julphar
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot